Did you miss our Conference Call on IBM? Watch the replay here. HIDE

CytRx (CYTR)

Add to Watchlists Create an Alert
3.26 -0.08  -2.40% NASDAQ Jul 31, 4:59PM BATS Real time Currency in USD
View Full Chart
CYTR Price Chart
View All Events

CYTR Events

Date Type Description
06/24/2014 10:00 PDT Misc AGM Event for CytRx Corp
06/24/2014 Misc Annual General Meeting for CytRx Corp
05/01/2014 Earnings CytRx Corp 1Q2014 Earning Result.
03/05/2014 Earnings CytRx Corporation Q4 2013 Earnings Results. Estimate: -0.21.
10/29/2013 Earnings CytRx Reports 2013 Third Quarter Financial Results. Estimate: -0.20.
08/06/2013 Earnings CytRx Reports 2013 Second Quarter Financial Results. Estimate: -0.21.
View All Performance Charts

CYTR Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). CytRx is up 35.27% over the last year vs S&P 500 Total Return up 16.94%, Northwest Biotherapeutics up 84.12%, and Nektar Therapeutics down 6.64%.

Get Quote for

Portfolio Strategies Featuring CYTR

Did CytRx make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CYTR Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.cytrx.com
  • IR Website: http://www.cytrx.com/investors
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

CytRx Corp is a biopharmaceutical research and development company specializing in oncology. Its oncology pipeline includes three clinical-stage drug candidates in various stages of development: Aldoxorubicin, Tamibarotene, and Bafetinib.

CYTR Excel Add-In Codes

  • Name: =YCI("CYTR","name")
  • Description: =YCI("CYTR","description")
  • Sector: =YCI("CYTR","sector")
  • Industry: =YCI("CYTR","industry")
  • Est. Current Fiscal Year End: =YCI("CYTR","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership


{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.